Literature DB >> 27138089

Targeted Modification of Mitochondrial ROS Production Converts High Glucose-Induced Cytotoxicity to Cytoprotection: Effects on Anesthetic Preconditioning.

Filip Sedlic1, Maria Y Muravyeva2, Ana Sepac3, Marija Sedlic2, Anna Marie Williams2, Meiying Yang2, Xiaowen Bai4, Zeljko J Bosnjak4.   

Abstract

Contradictory reports on the effects of diabetes and hyperglycemia on myocardial infarction range from cytotoxicity to cytoprotection. The study was designed to investigate acute effects of high glucose-driven changes in mitochondrial metabolism and osmolarity on adaptive mechanisms and resistance to oxidative stress of isolated rat cardiomyocytes. We examined the effects of high glucose on several parameters of mitochondrial bioenergetics, including changes in oxygen consumption, mitochondrial membrane potential, and NAD(P)H fluorometry. Effects of high glucose on the endogenous cytoprotective mechanisms elicited by anesthetic preconditioning (APC) and the mediators of cell injury were also tested. These experiments included real-time measurements of reactive oxygen species (ROS) production and mitochondrial permeability transition pore (mPTP) opening in single cells by laser scanning fluorescence confocal microscopy, and cell survival assay. High glucose rapidly enhanced mitochondrial energy metabolism, observed by increase in NAD(P)H fluorescence intensity, oxygen consumption, and mitochondrial membrane potential. This substantially elevated production of ROS, accelerated opening of the mPTP, and decreased survival of cells exposed to oxidative stress. Abrogation of high glucose-induced mitochondrial hyperpolarization with 2,4 dinitrophenol (DNP) significantly, but not completely, attenuated ROS production to a level similar to hyperosmotic mannitol control. DNP treatment reversed high glucose-induced cytotoxicity to cytoprotection. Hyperosmotic mannitol treatment also induced cytoprotection. High glucose abrogated APC-induced mitochondrial depolarization, delay in mPTP opening and cytoprotection. In conclusion, high glucose-induced mitochondrial hyperpolarization abolishes APC and augments cell injury. Attenuation of high glucose-induced ROS production by eliminating mitochondrial hyperpolarization protects cardiomyocytes. J. Cell. Physiol. 232: 216-224, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27138089      PMCID: PMC5028252          DOI: 10.1002/jcp.25413

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  52 in total

1.  Fluorometric measurement of reduced pyridine nucleotide in cellular and subcellular particles.

Authors:  R W ESTABROOK
Journal:  Anal Biochem       Date:  1962-09       Impact factor: 3.365

2.  Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytes.

Authors:  Filip Sedlic; Danijel Pravdic; Naoyuki Hirata; Yasushi Mio; Ana Sepac; Amadou K Camara; Tetsuro Wakatsuki; Zeljko J Bosnjak; Martin Bienengraeber
Journal:  Biochim Biophys Acta       Date:  2010-07-17

3.  Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress.

Authors:  Angelo Avogaro; Elisa Pagnin; Lorenzo Calò
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1.

Authors:  Magali Balteau; Nicolas Tajeddine; Carole de Meester; Audrey Ginion; Christine Des Rosiers; Nathan R Brady; Caroline Sommereyns; Sandrine Horman; Jean-Louis Vanoverschelde; Philippe Gailly; Louis Hue; Luc Bertrand; Christophe Beauloye
Journal:  Cardiovasc Res       Date:  2011-08-22       Impact factor: 10.787

5.  Effects of acute hyperglycemia on myocardial glycolytic activity in humans.

Authors:  J A Wisneski; W C Stanley; R A Neese; E W Gertz
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

6.  Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+.

Authors:  Filip Sedlic; Ana Sepac; Danijel Pravdic; Amadou K S Camara; Martin Bienengraeber; Anna K Brzezinska; Tetsuro Wakatsuki; Zeljko J Bosnjak
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-02       Impact factor: 4.249

7.  Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.

Authors:  Derek J Hausenloy; Michael R Duchen; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

8.  Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state.

Authors:  Anatoly A Starkov; Gary Fiskum
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

9.  Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology.

Authors:  Tianzheng Yu; James L Robotham; Yisang Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

Review 10.  Signal transduction by reactive oxygen species.

Authors:  Toren Finkel
Journal:  J Cell Biol       Date:  2011-07-11       Impact factor: 10.539

View more
  10 in total

1.  Identity and function of a cardiac mitochondrial small conductance Ca2+-activated K+ channel splice variant.

Authors:  MeiYing Yang; Amadou K S Camara; Mohammed Aldakkak; Wai-Meng Kwok; David F Stowe
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-03-22       Impact factor: 3.991

Review 2.  Non-linear actions of physiological agents: Finite disarrangements elicit fitness benefits.

Authors:  Filip Sedlic; Zdenko Kovac
Journal:  Redox Biol       Date:  2017-05-18       Impact factor: 11.799

3.  High glucose suppresses the viability and proliferation of HTR‑8/SVneo cells through regulation of the miR‑137/PRKAA1/IL‑6 axis.

Authors:  Hai-Yan Peng; Ming-Qing Li; Hua-Ping Li
Journal:  Int J Mol Med       Date:  2018-05-17       Impact factor: 4.101

Review 4.  The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer.

Authors:  Yina Yu; Liang Gong; Jun Ye
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

5.  Downregulation of hsa_circ_0005243 induces trophoblast cell dysfunction and inflammation via the β-catenin and NF-κB pathways.

Authors:  Huiyan Wang; Wenbo Zhou; Guangtong She; Bin Yu; Lizhou Sun
Journal:  Reprod Biol Endocrinol       Date:  2020-05-20       Impact factor: 5.211

Review 6.  Multiple Mechanisms Regulate Eukaryotic Cytochrome C Oxidase.

Authors:  Rabia Ramzan; Bernhard Kadenbach; Sebastian Vogt
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

7.  Accumulated ROS Activates HIF-1α-Induced Glycolysis and Exerts a Protective Effect on Sensory Hair Cells Against Noise-Induced Damage.

Authors:  Shuo Liang; Shuohui Dong; Wenwen Liu; Man Wang; Shanshan Tian; Yu Ai; Haibo Wang
Journal:  Front Mol Biosci       Date:  2022-01-12

Review 8.  Reactive Oxygen Species and Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and Cancer Progression.

Authors:  Jan Ježek; Katrina F Cooper; Randy Strich
Journal:  Antioxidants (Basel)       Date:  2018-01-16

Review 9.  Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heart.

Authors:  Tomo Svaguša; Mislav Martinić; Matea Martinić; Lucija Kovačević; Ana Šepac; Davor Miličić; Joško Bulum; Boris Starčević; Maja Sirotković-Skerlev; Fran Seiwerth; Ana Kulić; Filip Sedlić
Journal:  Croat Med J       Date:  2020-04-30       Impact factor: 1.351

10.  Increased Glycolysis and Higher Lactate Production in Hyperglycemic Myotubes.

Authors:  Jenny Lund; D Margriet Ouwens; Marianne Wettergreen; Siril S Bakke; G Hege Thoresen; Vigdis Aas
Journal:  Cells       Date:  2019-09-18       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.